EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Resistance training and protein supplementation in patients with incurable gastroesophageal cancer: a randomized feasibility trial

Rikke Krabek, Kasper Birch Kristensen, Simon Nørskov Thomsen, Anne Hauge Sørensen, Pernille Lykke Christensen, Kit Crusell Pedersen, Ane Rytter, Christina M Dieli-Conwright, Charlotte Suetta, Lykke Sylow, Bente Klarlund Pedersen, Morten Mau-Sørensen und 1 weitere

Supportive Care in Cancer · 2026-11 · 34 (11)

DOI: 10.1007/s00520-026-11430-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 05.11.2026. Verfasst von Rikke Krabek und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Physical Activity Research, University Hospital Copenhagen, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Cachexia, Dietary Proteins, Dietary Supplements, Esophageal Neoplasms. Die Arbeit nennt 43 Literaturangaben. Gefördert von: TrygFonden, Helsefonden, Region Hovedstaden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cancer cachexia is associated with reduced physical performance, quality of life, and survival in patients with incurable gastroesophageal cancer. Resistance training and protein supplementation have the potential to improve these outcomes. Whether an intervention comprising resistance training and protein supplementation is feasible during treatment for incurable gastroesophageal cancer is not known.

Methods

This was an open-label, parallel-group, two-arm, randomized controlled feasibility trial. Patients with incurable gastroesophageal cancer scheduled to undergo first-line chemotherapy were randomized 2:1 to resistance training three times per week and daily protein supplementation or to control. The primary outcome, feasibility, was assessed by recruitment, retention, adherence, and harms. Secondary outcomes included body composition, physical performance, quality of life, and treatment tolerability.

Results

Out of 106 potentially eligible patients, 20 participants (5 female and 15 male, mean age 65) were randomized yielding a recruitment rate of 19%. 18 participants completed the trial with a retention rate of 90%. Median (25th; 75th percentile) adherence to the resistance training sessions and to the protein supplements was 63% (43; 77) and 39% (17; 76), respectively. Five participants (38%) met the minimum feasibility criteria of both interventions. No serious adverse events related to the intervention occurred. We found no between-group differences in body composition, physical performance, quality of life, or treatment tolerability.

Conclusion

Resistance training combined with protein supplementation was not feasible during first-line chemotherapy in patients with incurable gastroesophageal cancer due to low accrual and low adherence to protein supplementation.

Trial registration

ClinicalTrials.gov NCT05650827. Study registration date 2022-12-12.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaDietary ProteinsDietary SupplementsEsophageal NeoplasmsResistance TrainingStomach NeoplasmsAgedFemaleHumansMaleMiddle AgedBody CompositionFeasibility StudiesPatient ComplianceQuality of Life

Stichwörter der Autor:innen

CachexiaCancerExerciseGastroesophageal cancerNutrition

Substanzen

Dietary Proteins

Autor:innen und Institutionen

  • Centre for Physical Activity Research, University Hospital Copenhagen, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
  • Department of Clinical Nutrition, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Geriatric Research Unit, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Förderung

  • TrygFonden
  • Helsefonden
  • Region Hovedstaden
  • Rigshospitalets Forskningsfond, Denmark

Zitieren

APA

Krabek, R., Kristensen, K. B., Thomsen, S. N., Sørensen, A. H., Christensen, P. L., Pedersen, K. C., Rytter, A., Dieli-Conwright, C. M., Suetta, C., Sylow, L., Pedersen, B. K., Mau-Sørensen, M., & Simonsen, C. (2026). Resistance training and protein supplementation in patients with incurable gastroesophageal cancer: a randomized feasibility trial. Supportive Care in Cancer, 34(11). https://doi.org/10.1007/s00520-026-11430-2

Vancouver

Krabek R, Kristensen KB, Thomsen SN, Sørensen AH, Christensen PL, Pedersen KC, et al. Resistance training and protein supplementation in patients with incurable gastroesophageal cancer: a randomized feasibility trial. Supportive Care in Cancer. 2026;34(11). doi:10.1007/s00520-026-11430-2

BibTeX
@article{Krabek2026,
  author = {Krabek, Rikke and Kristensen, Kasper Birch and Thomsen, Simon Nørskov and Sørensen, Anne Hauge and Christensen, Pernille Lykke and Pedersen, Kit Crusell and Rytter, Ane and Dieli-Conwright, Christina M and Suetta, Charlotte and Sylow, Lykke and Pedersen, Bente Klarlund and Mau-Sørensen, Morten and Simonsen, Casper},
  title = {Resistance training and protein supplementation in patients with incurable gastroesophageal cancer: a randomized feasibility trial},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {11},
  doi = {10.1007/s00520-026-11430-2}
}
Kostenlos starten →